Public list: Pharma Startups (6570) Eye Health (703)
NovelMed Therapeutics is a privately-held biotech company developing transformative treatments for orphan and non-orphan disease conditions. The company has developed a portfolio of antibodies targeted for the treatments of complement-mediated inflam...Show all
Company (Alive / Active)
Phone: 216-707-1776
BioEnterprise Building, 135
11000 Cedar Avenue
Cleveland, 44106
Ohio, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Aglycosylated human antibody and fusion protein and uses thereof | Dec 28, 2012 | Jul 14, 2020 | Patent |
Compositions and methods of treating ocular diseases | Jan 22, 2019 | Jun 30, 2020 | Patent |
Compositions and methods of treating ocular diseases | Aug 06, 2014 | Jan 22, 2019 | Patent |
Method of inhibiting complement activation with factor bb specific antibodies and use thereof | Mar 16, 2015 | Nov 20, 2018 | Patent |
Alternative pathway specific antibodies for treating hemolytic diseases | Apr 06, 2015 | Jun 05, 2018 | Patent |